Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 182 entries
Sorted by: Best Match Show Resources per page
Knowledge, Attitude and Advice-Giving Behaviour of Community Pharmacists Regarding Topical Corticosteroids.

Pharmacy (Basel, Switzerland)

Lau WM, Donyai P.
PMID: 28970453
Pharmacy (Basel). 2017 Jul 25;5(3). doi: 10.3390/pharmacy5030041.

This study examines the relationship between community pharmacists' knowledge, attitudes to information provision and self-reported counselling behaviours in relation to topical corticosteroids and adjunct therapy in atopic eczema. A mixed-methods approach was used whereby data from interviews with community...

Cite
Lau WM, Donyai P. Knowledge, Attitude and Advice-Giving Behaviour of Community Pharmacists Regarding Topical Corticosteroids. Pharmacy (Basel). 2017;5(3)doi: 10.3390/pharmacy5030041.
Lau, W. M., & Donyai, P. (2017). Knowledge, Attitude and Advice-Giving Behaviour of Community Pharmacists Regarding Topical Corticosteroids. Pharmacy (Basel, Switzerland), 5(3), . https://doi.org/10.3390/pharmacy5030041
Lau, Wing Man, and Donyai, Parastou. "Knowledge, Attitude and Advice-Giving Behaviour of Community Pharmacists Regarding Topical Corticosteroids." Pharmacy (Basel, Switzerland) vol. 5,3 (2017). doi: https://doi.org/10.3390/pharmacy5030041
Lau WM, Donyai P. Knowledge, Attitude and Advice-Giving Behaviour of Community Pharmacists Regarding Topical Corticosteroids. Pharmacy (Basel). 2017 Jul 25;5(3). doi: 10.3390/pharmacy5030041. PMID: 28970453; PMCID: PMC5622353.
Copy Download .nbib Format: NLM
Recalcitrant Digital Porokeratosis of Mibelli: A Successful Surgical Treatment.

North American journal of medical sciences

Shahmoradi Z, Sadeghiyan H, Pourazizi M, Saber M, Abtahi-Naeini B.
PMID: 26199929
N Am J Med Sci. 2015 Jun;7(6):295-6. doi: 10.4103/1947-2714.157485.

CONTEXT: Porokeratosis of Mibelli (PM) is a rare, benign, asymptomatic, epidermal hyperkeratinization dermatitis that is characterized by annular plaque that expands through the edges and leaves an atrophic center. Many therapies have been attempted for the treatment of PM,...

Cite
Shahmoradi Z, Sadeghiyan H, Pourazizi M, et al. Recalcitrant Digital Porokeratosis of Mibelli: A Successful Surgical Treatment. N Am J Med Sci. 2015;7(6):295-6doi: 10.4103/1947-2714.157485.
Shahmoradi, Z., Sadeghiyan, H., Pourazizi, M., Saber, M., & Abtahi-Naeini, B. (2015). Recalcitrant Digital Porokeratosis of Mibelli: A Successful Surgical Treatment. North American journal of medical sciences, 7(6), 295-6. https://doi.org/10.4103/1947-2714.157485
Shahmoradi, Zabihollah, et al. "Recalcitrant Digital Porokeratosis of Mibelli: A Successful Surgical Treatment." North American journal of medical sciences vol. 7,6 (2015): 295-6. doi: https://doi.org/10.4103/1947-2714.157485
Shahmoradi Z, Sadeghiyan H, Pourazizi M, Saber M, Abtahi-Naeini B. Recalcitrant Digital Porokeratosis of Mibelli: A Successful Surgical Treatment. N Am J Med Sci. 2015 Jun;7(6):295-6. doi: 10.4103/1947-2714.157485. PMID: 26199929; PMCID: PMC4488999.
Copy Download .nbib Format: NLM
Use of emollients in atopic dermatitis: a questionnaire survey study.

Annals of dermatology

Lee JH, Jung KE, Lee YB, Kim JE, Kim HS, Lee KH, Park YM, Cho SH, Lee JY.
PMID: 25143690
Ann Dermatol. 2014 Aug;26(4):528-31. doi: 10.5021/ad.2014.26.4.528. Epub 2014 Jul 31.

No abstract available.

Cite
Lee JH, Jung KE, Lee YB, et al. Use of emollients in atopic dermatitis: a questionnaire survey study. Ann Dermatol. 2014;26(4):528-31doi: 10.5021/ad.2014.26.4.528.
Lee, J. H., Jung, K. E., Lee, Y. B., Kim, J. E., Kim, H. S., Lee, K. H., Park, Y. M., Cho, S. H., & Lee, J. Y. (2014). Use of emollients in atopic dermatitis: a questionnaire survey study. Annals of dermatology, 26(4), 528-31. https://doi.org/10.5021/ad.2014.26.4.528
Lee, Ji Hyun, et al. "Use of emollients in atopic dermatitis: a questionnaire survey study." Annals of dermatology vol. 26,4 (2014): 528-31. doi: https://doi.org/10.5021/ad.2014.26.4.528
Lee JH, Jung KE, Lee YB, Kim JE, Kim HS, Lee KH, Park YM, Cho SH, Lee JY. Use of emollients in atopic dermatitis: a questionnaire survey study. Ann Dermatol. 2014 Aug;26(4):528-31. doi: 10.5021/ad.2014.26.4.528. Epub 2014 Jul 31. PMID: 25143690; PMCID: PMC4135116.
Copy Download .nbib Format: NLM
Cupping Therapy May be Harmful for Eczema: A PubMed Search.

Case reports in pediatrics

Hon KL, Luk DC, Leong KF, Leung AK.
PMID: 24282650
Case Rep Pediatr. 2013;2013:605829. doi: 10.1155/2013/605829. Epub 2013 Oct 27.

Eczema is a common childhood atopic condition and treatment is with emollients, topical corticosteroids, and avoidance of possible triggers. S. aureus colonization is a common complication. As there is no immediate cure, many parents seek alternative therapies that claim...

Cite
Hon KL, Luk DC, Leong KF, et al. Cupping Therapy May be Harmful for Eczema: A PubMed Search. Case Rep Pediatr. 2013;2013:605829doi: 10.1155/2013/605829.
Hon, K. L., Luk, D. C., Leong, K. F., & Leung, A. K. (2013). Cupping Therapy May be Harmful for Eczema: A PubMed Search. Case reports in pediatrics, 2013605829. https://doi.org/10.1155/2013/605829
Hon, Kam Lun E, et al. "Cupping Therapy May be Harmful for Eczema: A PubMed Search." Case reports in pediatrics vol. 2013 (2013): 605829. doi: https://doi.org/10.1155/2013/605829
Hon KL, Luk DC, Leong KF, Leung AK. Cupping Therapy May be Harmful for Eczema: A PubMed Search. Case Rep Pediatr. 2013;2013:605829. doi: 10.1155/2013/605829. Epub 2013 Oct 27. PMID: 24282650; PMCID: PMC3825217.
Copy Download .nbib Format: NLM
Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review.

World journal of clinical pediatrics

Sathiyamurthy S, Banerjee J, Godambe SV.
PMID: 27170926
World J Clin Pediatr. 2016 May 08;5(2):159-71. doi: 10.5409/wjcp.v5.i2.159. eCollection 2016 May 08.

Infants in the neonatal intensive care unit are highly susceptible to healthcare associated infections (HAI), with a substantial impact on mortality, morbidity and healthcare costs. Effective skin disinfection with topical antiseptic agents is an important intervention in the prevention...

Cite
Sathiyamurthy S, Banerjee J, Godambe SV. Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review. World J Clin Pediatr. 2016;5(2):159-71doi: 10.5409/wjcp.v5.i2.159.
Sathiyamurthy, S., Banerjee, J., & Godambe, S. V. (2016). Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review. World journal of clinical pediatrics, 5(2), 159-71. https://doi.org/10.5409/wjcp.v5.i2.159
Sathiyamurthy, Sundar, et al. "Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review." World journal of clinical pediatrics vol. 5,2 (2016): 159-71. doi: https://doi.org/10.5409/wjcp.v5.i2.159
Sathiyamurthy S, Banerjee J, Godambe SV. Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review. World J Clin Pediatr. 2016 May 08;5(2):159-71. doi: 10.5409/wjcp.v5.i2.159. eCollection 2016 May 08. PMID: 27170926; PMCID: PMC4857229.
Copy Download .nbib Format: NLM
Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study.

Evidence-based complementary and alternative medicine : eCAM

Kobayashi H, Ishii M, Takeuchi S, Tanaka Y, Shintani T, Yamatodani A, Kusunoki T, Furue M.
PMID: 18955318
Evid Based Complement Alternat Med. 2010 Sep;7(3):367-73. doi: 10.1093/ecam/nen003. Epub 2008 Jan 31.

Hochu-ekki-to is a traditional herbal (Kampo) medicine that has been shown to be effective for patients with Kikyo (delicate, easily fatigable, or hypersensitive) constitution. Previous case reports have suggested that this herbal drug was effective for a certain subgroup...

Cite
Kobayashi H, Ishii M, Takeuchi S, et al. Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study. Evid Based Complement Alternat Med. 2008;7(3):367-73doi: 10.1093/ecam/nen003.
Kobayashi, H., Ishii, M., Takeuchi, S., Tanaka, Y., Shintani, T., Yamatodani, A., Kusunoki, T., & Furue, M. (2010). Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study. Evidence-based complementary and alternative medicine : eCAM, 7(3), 367-73. https://doi.org/10.1093/ecam/nen003
Kobayashi, Hiromi, et al. "Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study." Evidence-based complementary and alternative medicine : eCAM vol. 7,3 (2010): 367-73. doi: https://doi.org/10.1093/ecam/nen003
Kobayashi H, Ishii M, Takeuchi S, Tanaka Y, Shintani T, Yamatodani A, Kusunoki T, Furue M. Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study. Evid Based Complement Alternat Med. 2010 Sep;7(3):367-73. doi: 10.1093/ecam/nen003. Epub 2008 Jan 31. PMID: 18955318; PMCID: PMC2887326.
Copy Download .nbib Format: NLM
Water vapour permeability of skin care products in relation to molecular and environmental influences.

International journal of cosmetic science

Strübmann A, Weißen HJ, Wirtz A.
PMID: 19281613
Int J Cosmet Sci. 1993 Dec;15(6):227-33. doi: 10.1111/j.1467-2494.1993.tb00569.x.

Synopsis An in vitro method for characterization of water retention behaviour of emollients was developed. The human skin is imitated with the aid of a polytetrafluoro ethylene membrane and the degree of water vapour evaporation after impregnation with different...

Cite
Strübmann A, Weißen HJ, Wirtz A. Water vapour permeability of skin care products in relation to molecular and environmental influences. Int J Cosmet Sci. 1993;15(6):227-33doi: 10.1111/j.1467-2494.1993.tb00569.x.
Strübmann, A., Weißen, H. J., & Wirtz, A. (1993). Water vapour permeability of skin care products in relation to molecular and environmental influences. International journal of cosmetic science, 15(6), 227-33. https://doi.org/10.1111/j.1467-2494.1993.tb00569.x
Strübmann, A, et al. "Water vapour permeability of skin care products in relation to molecular and environmental influences." International journal of cosmetic science vol. 15,6 (1993): 227-33. doi: https://doi.org/10.1111/j.1467-2494.1993.tb00569.x
Strübmann A, Weißen HJ, Wirtz A. Water vapour permeability of skin care products in relation to molecular and environmental influences. Int J Cosmet Sci. 1993 Dec;15(6):227-33. doi: 10.1111/j.1467-2494.1993.tb00569.x. PMID: 19281613.
Copy Download .nbib Format: NLM
Olmsted syndrome.

Case reports in dermatological medicine

Elise Tonoli R, De Villa D, Hübner Frainer R, Pizzarro Meneghello L, Ricachnevsky N, de Quadros M.
PMID: 23320205
Case Rep Dermatol Med. 2012;2012:927305. doi: 10.1155/2012/927305. Epub 2012 Dec 23.

Olmsted syndrome is a rare congenital, sharply circumscribed transgredient palmoplantar keratoderma. It was first described by Olmsted in 1927. The diagnosis of this rare disease depends on clinical features like symmetrical involvement of keratoderma of the palms and soles...

Cite
Elise Tonoli R, De Villa D, Hübner Frainer R, et al. Olmsted syndrome. Case Rep Dermatol Med. 2012;2012:927305doi: 10.1155/2012/927305.
Elise Tonoli, R., De Villa, D., Hübner Frainer, R., Pizzarro Meneghello, L., Ricachnevsky, N., & de Quadros, M. (2012). Olmsted syndrome. Case reports in dermatological medicine, 2012927305. https://doi.org/10.1155/2012/927305
Elise Tonoli, Renata, et al. "Olmsted syndrome." Case reports in dermatological medicine vol. 2012 (2012): 927305. doi: https://doi.org/10.1155/2012/927305
Elise Tonoli R, De Villa D, Hübner Frainer R, Pizzarro Meneghello L, Ricachnevsky N, de Quadros M. Olmsted syndrome. Case Rep Dermatol Med. 2012;2012:927305. doi: 10.1155/2012/927305. Epub 2012 Dec 23. PMID: 23320205; PMCID: PMC3540698.
Copy Download .nbib Format: NLM
Update on the management of chronic eczema: new approaches and emerging treatment options.

Clinical, cosmetic and investigational dermatology

Walling HW, Swick BL.
PMID: 21437065
Clin Cosmet Investig Dermatol. 2010 Jul 28;3:99-117. doi: 10.2147/ccid.s6496.

Atopic dermatitis (AD) is a common disease with worldwide prevalence, affecting up to 20% of children and 3% of adults. Recent evidence regarding pathogenesis has implicated epidermal barrier defects deriving from filagrin mutations with resulting secondary inflammation. In this...

Cite
Walling HW, Swick BL. Update on the management of chronic eczema: new approaches and emerging treatment options. Clin Cosmet Investig Dermatol. 2010;3:99-117doi: 10.2147/ccid.s6496.
Walling, H. W., & Swick, B. L. (2010). Update on the management of chronic eczema: new approaches and emerging treatment options. Clinical, cosmetic and investigational dermatology, 399-117. https://doi.org/10.2147/ccid.s6496
Walling, Hobart W, and Swick, Brian L. "Update on the management of chronic eczema: new approaches and emerging treatment options." Clinical, cosmetic and investigational dermatology vol. 3 (2010): 99-117. doi: https://doi.org/10.2147/ccid.s6496
Walling HW, Swick BL. Update on the management of chronic eczema: new approaches and emerging treatment options. Clin Cosmet Investig Dermatol. 2010 Jul 28;3:99-117. doi: 10.2147/ccid.s6496. PMID: 21437065; PMCID: PMC3047944.
Copy Download .nbib Format: NLM
Therapy of atopic eczema.

GMS health technology assessment

Werfel T, Claes C, Kulp W, Greiner W, von der Schulenburg JM.
PMID: 21289970
GMS Health Technol Assess. 2006 Oct 06;2:Doc19.

OBJECTIVES: Major objective is the evaluation of the medical effectiveness of different therapeutical approaches and the cost effectiveness with relevance for Germany.METHODS: This health technology assessment (HTA) evaluates systemically randomized controlled studies (RCT) on the therapy of atopic dermatitis...

Cite
Werfel T, Claes C, Kulp W, et al. Therapy of atopic eczema. GMS Health Technol Assess. 2006;2:Doc19
Werfel, T., Claes, C., Kulp, W., Greiner, W., & von der Schulenburg, J. M. (2006). Therapy of atopic eczema. GMS health technology assessment, 2Doc19.
Werfel, Thomas, et al. "Therapy of atopic eczema." GMS health technology assessment vol. 2 (2006): Doc19.
Werfel T, Claes C, Kulp W, Greiner W, von der Schulenburg JM. Therapy of atopic eczema. GMS Health Technol Assess. 2006 Oct 06;2:Doc19. PMID: 21289970; PMCID: PMC3011357.
Copy Download .nbib Format: NLM
Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam.

Clinical, cosmetic and investigational dermatology

Pacha O, Hebert AA.
PMID: 22690129
Clin Cosmet Investig Dermatol. 2012;5:39-42. doi: 10.2147/CCID.S23269. Epub 2012 May 07.

Advances in current understanding of the pathophysiology of atopic dermatitis have led to improved targeting of the structural deficiencies in atopic skin. Ceramide deficiency appears to be one of the major alterations in atopic dermatitis and the replenishment of...

Cite
Pacha O, Hebert AA. Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam. Clin Cosmet Investig Dermatol. 2012;5:39-42doi: 10.2147/CCID.S23269.
Pacha, O., & Hebert, A. A. (2012). Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam. Clinical, cosmetic and investigational dermatology, 539-42. https://doi.org/10.2147/CCID.S23269
Pacha, Omar, and Hebert, Adelaide A. "Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam." Clinical, cosmetic and investigational dermatology vol. 5 (2012): 39-42. doi: https://doi.org/10.2147/CCID.S23269
Pacha O, Hebert AA. Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam. Clin Cosmet Investig Dermatol. 2012;5:39-42. doi: 10.2147/CCID.S23269. Epub 2012 May 07. PMID: 22690129; PMCID: PMC3363028.
Copy Download .nbib Format: NLM
Methods to Assess the Protective Efficacy of Emollients against Climatic and Chemical Aggressors.

Dermatology research and practice

Roure R, Lanctin M, Nollent V, Bertin C.
PMID: 22952472
Dermatol Res Pract. 2012;2012:864734. doi: 10.1155/2012/864734. Epub 2012 Aug 16.

Exposure to harsh environmental conditions, such as cold and dry climate and chemicals can have an abrasive effect on skin. Skin care products containing ingredients that avert these noxious effects by reinforcement of the barrier function can be tested...

Cite
Roure R, Lanctin M, Nollent V, et al. Methods to Assess the Protective Efficacy of Emollients against Climatic and Chemical Aggressors. Dermatol Res Pract. 2012;2012:864734doi: 10.1155/2012/864734.
Roure, R., Lanctin, M., Nollent, V., & Bertin, C. (2012). Methods to Assess the Protective Efficacy of Emollients against Climatic and Chemical Aggressors. Dermatology research and practice, 2012864734. https://doi.org/10.1155/2012/864734
Roure, Romain, et al. "Methods to Assess the Protective Efficacy of Emollients against Climatic and Chemical Aggressors." Dermatology research and practice vol. 2012 (2012): 864734. doi: https://doi.org/10.1155/2012/864734
Roure R, Lanctin M, Nollent V, Bertin C. Methods to Assess the Protective Efficacy of Emollients against Climatic and Chemical Aggressors. Dermatol Res Pract. 2012;2012:864734. doi: 10.1155/2012/864734. Epub 2012 Aug 16. PMID: 22952472; PMCID: PMC3431057.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 182 entries